Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

por Buchholz, M., Majchrzak-Stiller, B., Hahn, S., Vangala, D., Pfirrmann, R. W., Uhl, W., Braumann, C., Chromik, A. M.
Publicado 2017